Yet, what level (i.e., how many MET gene copies) should be reached in order to induce substantially increased MET-expression and ligand-independent sustained activation of MET signaling with clinically relevant oncogenic effect is unclear and may vary according to tumor type. Here, MET is linked to neoplasm.